Peng Liu

32PUBLICATIONS

19CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)ClinimetricsRegenerative medicine (incl. stem cells)Immunogenetics (incl. genetic immunology)Epidemiological modelling

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (32)

Sort by Publication Date:

|Jul 11, 2026

The efficacy, safety, and rationale of orelabrutinib combined with obinutuzumab (O2) as a first-line systemic treatment for marginal zone lymphoma.

|Jun 23, 2026

A Multicenter National Study of AL Amyloidosis in China: Insights Into Real-World Diagnosis, Treatment, and Prognosis.

|Mar 12, 2026

Dynamic biomarker-based machine learning model predicts short-term treatment response in multiple myeloma.

Yaqin Xiong, Jiadai Xu, Bingjie Li

|Mar 04, 2026

Imeglimin Exerts Anti-Tumor Activity in Multiple Myeloma Through Affecting Energy Metabolism and Downregulating IL-16 Expression.

Jifeng Jiang, Liang Ren, Yifeng Sun

|Nov 08, 2025

Real-World Data Analysis on Early Mortality in Chinese Multiple Myeloma Patients: Analysis of 1093 Patients During a 15-Year Period.

Xue Yang, Pu Wang, Tianhong Xu

|Sep 18, 2025

Myocardial work indices in the short-term prognosis of light-chain cardiac amyloidosis: Incremental value beyond traditional staging models and echocardiographic parameters.

Fangmin Meng, Jing Li, Rui Zhao

Pageof 6

Frequent Collaborators

Yuhong Ren

Panpan Li

Jiadai Xu

Chen Chen

Tianhong Xu

Yue Wang

Liang Ren

Yian Zhang

Xue Yang

Yawen Wang

Frequent Collaborators

Yuhong Ren

Panpan Li

Jiadai Xu

Chen Chen